Kelyniam Global Announces 510(k) Clearance for Integrated Fixation System for Custom Skull Implants

OrthoNext Digital Platform for the JuniOrtho Plating System Receives FDA Clearance

“Together, OrthoNext and the JuniOrtho Plating System provide a complete solution for surgeons looking for a plating system to address the specific demands of advanced deformity and trauma reconstruction of the lower extremities in the pediatric population,” said Orthofix President of Global Orthopedics Paul Gonsalves.

SonarMed, New Pediatric Monitor Alerts Clinicians To Potential Airway Obstructions During Ventilation Launched

"The SonarMed airway monitoring device has revolutionized the way we care for our littlest patients. There is no other device in the world that can tell you where the endotracheal tube is located within the airway continuously in real-time, and whether the tube is obstructed or even partially occluded," said Jamie W. Powers, M.D., MBA, neonatologist at Huntington Hospital in Pasadena, California.

Kelyniam Global (KLYG), a maker of custom cranial and craniofacial implants, announced today that it has received premarket approval from the Food and Drug Administration (FDA) for a new 510(k) application that allows for unique modifications to their PEEK cranio-maxillofacial implant product line.

Custom Skull ImplantsThis approval means Kelyniam can now sell the only approved PEEK cranial implant with an integrated fixation system (IFS).  IFS Tabs© can eliminate the need for cranioplasty plates, saving hundreds of dollars per procedure. Surgeons can determine where the fixation tabs are placed around the implant to ensure a precise fit.

The comprehensive 510(k) application included additional modifications that are now only available on Kelyniam’s PEEK implants.  Eric Boyea, Director of Quality and Regulatory Affairs, said, “Kelyniam has a proven process for 510(k) submissions and worked closely with the FDA to ensure the review process went smoothly.  We are excited about this approval because surgeons can now request Kelyniam implants to include a temporal cutback to help streamline implantation by reducing the need for difficult dissection when needed.  Surgeons also have the option to include perfusion holes to allow communication with the subgaleal space when needed.”

Dr. Mark Smith, Kelyniam’s VP of Business Development said, “I know from first-hand experience and from discussions with colleagues just how much easier and faster securing the implant is with the IFS Tabs©.”

“Our distributor partners have been eagerly waiting for this approval,” said Laura Reed, Kelyniam’s National Sales Director.  “These unique enhancements, many which are now only approved for Kelyniam implants, will differentiate our products in the market.  In addition, these new features can be included within our current 24-hour turnaround time.”

Ross Bjella, Kelyniam’s Chairman and CEO, said, “Kelyniam has once again proven our ability to work closely with surgeons and the FDA to bring innovative products to the market. Our commitment to providing unique products that meet or exceed customer needs is evident in this comprehensive application.”

Kelyniam expects to start shipping the enhanced implants in June.



Subscribe to Medical Device News Magazine here.

Related Articles